Ceftriaxone
U1111-1189-1653
Phase 3 small_molecule active
Quick answer
Ceftriaxone for Community-acquired Pneumonia, Influenza, COVID-19 is a Phase 3 program (small_molecule) at Adaptive Biotechnologies Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Adaptive Biotechnologies Corp
- Indication
- Community-acquired Pneumonia, Influenza, COVID-19
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active